PIK3CA mutations in breast cancer are associated with poor outcome
- 30 November 2005
- journal article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 96 (1), 91-95
- https://doi.org/10.1007/s10549-005-9048-0
Abstract
The phosphatidylinositol-3-kinase (PI3K)–AKT signaling pathway is considered to play an important role in tumorigenesis. Frequent somatic mutations in the PI3K subunit p110α (PIK3CA) occur in a variety of cancer types. We screened 250 primary human breast tumors for mutations in PIK3CA in order to determine associations with pathological features and with patient outcome. The frequency of PIK3CA mutations in the C2, helical and kinase domains was 35% (88/250). Mutations were associated with larger tumor size (p=0.004) and positive estrogen receptor status (p=0.008). Patients with PIK3CA mutations showed significantly worse survival (p=0.004), particularly those with positive estrogen receptor expression or non-amplified erbB2 (both p=0.002). PIK3CA mutation was an independent factor for worse survival in breast cancer patients with non-amplified erbB2 (RR=2.6, 95%CI [1.2–5.5], p=0.016).Keywords
This publication has 15 references indexed in Scilit:
- Frequent Mutation of the PIK3CA Gene in Ovarian and Breast CancersClinical Cancer Research, 2005
- PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast CarcinomaCancer Research, 2005
- PIK3CA mutations in advanced ovarian carcinomasHuman Mutation, 2005
- PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomasOncogene, 2004
- Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotypeBreast Cancer Research and Treatment, 2004
- Mutation of the PIK3CA Gene in Ovarian and Breast CancerCancer Research, 2004
- The PIK3CA gene is mutated with high frequency in human breast cancersCancer Biology & Therapy, 2004
- High Frequency of Mutations of the PIK3CA Gene in Human CancersScience, 2004
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasInternational Journal of Cancer, 1995